FDA Drug Recalls

Recalls / Class II

Class IID-0558-2023

Product

Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0727-30) b) 90 count-bottle (NDC 43063-0727-90)

Affected lot / code info
Lots: a) K22E32 Exp. 10/31/23; b) H22C33 Exp. 09/30/23; H22C81, J22C83, K22E36 Exp. 10/31/23

Why it was recalled

CGMP deviations.

Recalling firm

Firm
PD-Rx Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
727 N Ann Arbor Ave, Oklahoma City, Oklahoma 73127-5822

Distribution

Quantity
37 bottles
Distribution pattern
Nationwide in the US.

Timeline

Recall initiated
2023-04-06
FDA classified
2023-05-01
Posted by FDA
2023-05-10
Terminated
2024-04-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0558-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.